Global Arachnoid Cysts Research Report: By Type (Intracranial & Spinal), by Diagnosis (CT Scan, MRI Scan, Prenatal Ultrasound, Other Tests), by Treatment (Permanent Drainage System Surgery, Fenestration, Endoscopic Cyst Fenestration)—Forecast till 2027
ID: MRFR/MED/5089-HCR | | Region: Global | 100 pages
Market Scenario
The global arachnoid cysts market is expected to grow slowly over the forecast period. It is estimated that the global arachnoid cysts market is expected to steadily grow during the forecast period of 2018–2023. Arachnoid cysts are a type of brain cyst cause between the split of the arachnoid membrane, which is one of the 3 layers of the tissue that covers the brain and the spinal cord.
Rising number of patients suffering from meningitis, tumors and head injuries are expected to drive the growth of the market. According to a report published by the American Society of Clinical Oncology in November 2017, an estimated 23,880 people are expected to be diagnosed with brain and spinal cord tumors in 2017.
Moreover, favorable healthcare expenditures boost the growth of the market. However, lack of knowledge may hamper the market growth during the assessment period.
Segmentation
The global arachnoid cysts market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into, intracranial and spinal. Intracranial arachnoid cysts are expected to hold the largest market share because of high incidences of the type. Spinal arachnoid cysts are expected to grow at the fastest CAGR owing to rising cases of spinal injuries resulting in cysts.
The market, by diagnosis, has been segmented into, CT scan, MRI scan, prenatal ultrasound, and other tests.
The market, by treatment, has been segmented into, permanent drainage system surgery, fenestration, and endoscopic cyst fenestration.
The market, by region, has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The arachnoid cysts market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European arachnoid cysts market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The arachnoid cysts market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The arachnoid cysts market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
Spiegelberg GmbH & Co. KG ., Sophysa, Aesculap, Inc., DePuy Synthes, Medtronic, Integra LifeSciences, Christoph Miethke GmbH & Co. KG, Tokibo Co. Ltd., Boston Neurosciences, Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Hitachi Medical Systems Europe, Siemens Healthcare Private Limited and FUJIFILM SonoSite, Inc. are some of the key players in the global arachnoid cysts market.
Regional Market Summary
Global Arachnoid Cysts Market Share (%), by Region, 2017
Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)
Geographically, the Americas is anticipated to dominate the global arachnoid cysts market owing to technological advancements and rising prevalence of tumor & meningitis. According to a report published by American Society of Clinical Oncology in November 2017, about 3,560 children are expected to be diagnosed with a brain tumor or CNS tumor in 2017.
Europe is expected to hold the second largest position in the global arachnoid cysts market. The market growth in this region is attributed to the growing prevalence of spinal cord & brain tumors and increasing healthcare expenditure. According to Cancer Research UK, 11,432 new cases of brain tumors were reported in 2015 in the UK.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the rising awareness of tumors & meningitis and government support for healthcare facilities. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cases of cancer in China in 2015.
On the other hand, the Middle East & Africa has the least market share. Majority of the market of this region is expected to be held by the Middle East region due to growing government initiatives for the improvement of the healthcare sector.
Global Arachnoid Cysts Market, by Type
- Intracranial
- Spinal
Global Arachnoid Cysts Market, by Diagnosis
- CT Scan
- MRI Scan
- Prenatal Ultrasound
- Other Tests
Global Arachnoid cysts Market, by Treatment
- Permanent Drainage System Surgery
- Fenestration
- Endoscopic Cyst Fenestration
Global Arachnoid Cysts Market, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Shunt Valves Manufacturers
- Medical Devices Suppliers & Manufacturers
- Research and Development (R&D) Companies
- Government and Independent Research Laboratories
- Market Research and Consulting Service Providers
- Academic Medical Institutes and Universities
Frequently Asked Questions (FAQ) :
Lack of knowledge may hamper the arachnoid cysts market.
The diagnosis part of arachnoid cysts market has CT scan, MRI scan, prenatal ultrasound, and other tests.
The Americas would top the arachnoid cysts market.
The fastest-growing regional arachnoid cysts market would be Asia Pacific.
Arachnoid cysts market in Europe would benefit from increasing spinal cord and brain tumor studies, along with high healthcare expenditures.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Arachnoid Cysts Market, by Type
6.1 Introduction
6.2 Intracranial
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Spinal
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Arachnoid Cysts Market, by Diagnosis
7.1 Introduction
7.2 CT Scan
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 MRI Scan
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Prenatal Ultrasound
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.7 Other Tests
Chapter 8. Global Arachnoid Cysts Market, by Treatment
8.1 Introduction
8.2 Permanent drainage system surgery
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Fenestration
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Endoscopic Cyst Fenestration
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Arachnoid Cysts Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Spiegelberg GmbH & Co. KG .
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Sophysa
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Aesculap, Inc.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 DePuy Synthes
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Medtronic
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Integra LifeSciences
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Christoph Miethke GmbH & Co. KG
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Tokibo Co. Ltd.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Boston Neurosciences
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Koninklijke Philips N.V.
11.10.1 Company Overview
11.10.2 Product Overview
11.10.3 Financial Overview
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 GENERAL ELECTRIC COMPANY
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financial Overview
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Hitachi Medical Systems Europe
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Siemens Healthcare Private Limited
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 FUJIFILM SonoSite, Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Arachnoid Cysts Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Arachnoid Cysts Market Synopsis, 2020-2027
Table 2 Global Arachnoid Cysts Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Arachnoid Cysts Market, by Region, 2020-2027 (USD Million)
Table 4 Global Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 5 Global Arachnoid Cysts Market, by Diagnosis, 2020-2027(USD Million)
Table 6 Global Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 7 North America: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 8 North America: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 9 North America: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 10 US: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 11 US: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 12 US: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 13 Canada: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 14 Canada: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 15 Canada: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 16 South America: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 17 South America: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 18 South America: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 19 Europe: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 20 Europe: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 21 Europe: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 22 Western Europe: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 23 Western Europe: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 24 Western Europe: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD
Million)
Table 25 Eastern Europe: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 26 Eastern Europe: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 27 Eastern Europe: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 28 Asia-Pacific: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 29 Asia-Pacific: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 30 Asia-Pacific: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD Million)
Table 31 Middle East & Africa: Arachnoid Cysts Market, by Type, 2020-2027 (USD Million)
Table 32 Middle East & Africa: Arachnoid Cysts Market, by Diagnosis, 2020-2027 (USD Million)
Table 33 Middle East & Africa: Arachnoid Cysts Market, by Treatment, 2020-2027 (USD
Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Arachnoid Cysts Market
Figure 3 Segmentation Market Dynamics for Global Arachnoid Cysts Market
Figure 4 Global Arachnoid Cysts Market Share, by Type, 2020
Figure 5 Global Arachnoid Cysts Market Share, by Diagnosis, 2020
Figure 6 Global Arachnoid Cysts Market Share, by Treatment, 2020
Figure 7 Global Arachnoid Cysts Market Share, by Region, 2020
Figure 8 North America: Arachnoid Cysts Market Share, by Country, 2020
Figure 9 Europe: Arachnoid Cysts Market Share, by Country, 2020
Figure 10 Asia-Pacific: Arachnoid Cysts Market Share, by Country, 2020
Figure 11 Middle East & Africa: Arachnoid Cysts Market Share, by Country, 2020
Figure 12 Global Arachnoid Cysts Market: Company Share Analysis, 2020 (%)
Figure 13 Spiegelberg GmbH & Co. KG .: Key Financials
Figure 14 Spiegelberg GmbH & Co. KG .: Segmental Revenue
Figure 15 Spiegelberg GmbH & Co. KG .: Geographical Revenue
Figure 16 Sophysa: Key Financials
Figure 17 Sophysa: Segmental Revenue
Figure 18 Sophysa: Geographical Revenue
Figure 19 Aesculap, Inc.: Key Financials
Figure 20 Aesculap, Inc.: Segmental Revenue
Figure 21 Aesculap, Inc.: Geographical Revenue
Figure 22 DePuy Synthes: Key Financials
Figure 23 DePuy Synthes: Segmental Revenue
Figure 24 DePuy Synthes: Geographical Revenue
Figure 25 Medtronic: Key Financials
Figure 26 Medtronic: Segmental Revenue
Figure 27 Medtronic: Geographical Revenue
Figure 28 Integra LifeSciences: Key Financials
Figure 29 Integra LifeSciences: Segmental Revenue
Figure 30 Integra LifeSciences: Geographical Revenue
Figure 31 Christoph Miethke GmbH & Co. KG: Key Financials
Figure 32 Christoph Miethke GmbH & Co. KG: Segmental Revenue
Figure 33 Christoph Miethke GmbH & Co. KG: Geographical Revenue
Figure 34 Tokibo Co. Ltd.: Financials
Figure 35 Tokibo Co. Ltd.: Segmental Revenue
Figure 36 Tokibo Co. Ltd.: Geographical Revenue
Figure 37 Boston Neurosciences: Key Financials
Figure 38 Boston Neurosciences: Segmental Revenue
Figure 39 Boston Neurosciences: Geographical Revenue
Figure 40 Koninklijke Philips N.V.: Key Financials
Figure 41 Koninklijke Philips N.V.: Segmental Revenue
Figure 42 Koninklijke Philips N.V.: Geographical Revenue
Figure 43 GENERAL ELECTRIC COMPANY: Key Financials
Figure 44 GENERAL ELECTRIC COMPANY: Segmental Revenue
Figure 45 GENERAL ELECTRIC COMPANY: Geographical Revenue
Figure 46 Hitachi Medical Systems Europe: Key Financials
Figure 47 Hitachi Medical Systems Europe: Segmental Revenue
Figure 48 Hitachi Medical Systems Europe: Geographical Revenue
Figure 49 Siemens Healthcare Private Limited: Financials
Figure 50 Siemens Healthcare Private Limited: Segmental Revenue
Figure 51 Siemens Healthcare Private Limited: Geographical Revenue
Figure 52 FUJIFILM SonoSite, Inc.: Key Financials
Figure 53 FUJIFILM SonoSite, Inc.: Segmental Revenue
Figure 54 FUJIFILM SonoSite, Inc.: Geographical Revenue
